TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:05
Avid Bioservices Inc. ( CDMO ) https://www.avidbio.com
12.28USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
CDMO
80.85%
SPY
32.66%
-58.06%
CDMO
SPY
108.59%
CDMO
52.36%
SPY
302.52%
CDMO
90.05%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
785.21
796.83
0.86
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-5.16
5.22
17.52
-4.21
0.00
-51.98
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-37.72
-6.11
-10.21
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.2816
-10.19
-6.27
1.62
Other Earnings and Cash Flow Stats:
Avid Bioservices Inc. ( CDMO ) Net Income TTM ($MM) is -152.05
Avid Bioservices Inc. ( CDMO ) Operating Income TTM ($MM) is -20.38
Avid Bioservices Inc. ( CDMO ) Owners' Earnings Annual ($MM) is 0.00
Avid Bioservices Inc. ( CDMO ) Current Price to Owners' Earnings ratio is 0.00
Avid Bioservices Inc. ( CDMO ) EBITDA TTM ($MM) is -7.90
Avid Bioservices Inc. ( CDMO ) EBITDA Margin is -10.21%
Capital Allocation:
Avid Bioservices Inc. ( CDMO ) has paid 0.00 dividends per share and bought back -0.689 million shares in the past 12 months
Avid Bioservices Inc. ( CDMO ) has reduced its debt by 292.674 million USD in the last 12 months
Capital Structure:
Avid Bioservices Inc. ( CDMO ) Interest-bearing Debt ($MM) as of last quarter is 45
Avid Bioservices Inc. ( CDMO ) Annual Working Capital Investments ($MM) are -9
Avid Bioservices Inc. ( CDMO ) Book Value ($MM) as of last quarter is 44
Avid Bioservices Inc. ( CDMO ) Debt/Capital as of last quarter is 100%
Other Balance Sheet Stats:
Avid Bioservices Inc. ( CDMO ) has 33 million in cash on hand as of last quarter
Avid Bioservices Inc. ( CDMO ) has 74 million of liabilities due within 12 months, and long term debt 295 as of last quarter
Avid Bioservices Inc. ( CDMO ) has 63 common shares outstanding as of last quarter
Avid Bioservices Inc. ( CDMO ) has 0 million USD of preferred stock value
Academic Scores:
Avid Bioservices Inc. ( CDMO ) Altman Z-Score is -0.63 as of last quarter
Avid Bioservices Inc. ( CDMO ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Avid Bioservices Inc. ( CDMO ) largest shareholder is owning shares at 0.00 ($MM) value
Kwietniak Matthew R.(an insider) Sold 119 shares of Avid Bioservices Inc. ( CDMO ) for the amount of $1207.86 on 2024-10-14
1.13% of Avid Bioservices Inc. ( CDMO ) is held by insiders, and 104.31% is held by institutions
Avid Bioservices Inc. ( CDMO ) went public on 2018-01-08
Other Avid Bioservices Inc. ( CDMO ) financial metrics:
FCF:-30.37
Unlevered Free Cash Flow:0.00
EPS:-1.09
Operating Margin:-37.72
Gross Profit Margin:-6.11
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-155.38
Beta:1.62
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Avid Bioservices Inc. ( CDMO ) :
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.